These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 31961195
1. Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction. Frydland M, Møller JE, Lindholm MG, Hansen R, Wiberg S, Lerche Helgestad OK, Thomsen JH, Goetze JP, Engstrøm T, Frikke-Schmidt R, Ravn HB, Holmvang L, Jensen LO, Kjaergaard J, Hassager C. Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):557-566. PubMed ID: 31961195 [Abstract] [Full Text] [Related]
2. Mortality in cardiogenic shock is stronger associated to clinical factors than contemporary biomarkers reflecting neurohormonal stress and inflammatory activation. Josiassen J, Frydland M, Holmvang L, Lerche Helgestad OK, Okkels Jensen L, Goetze JP, Eifer Møller J, Hassager C. Biomarkers; 2020 Sep; 25(6):506-512. PubMed ID: 32649233 [Abstract] [Full Text] [Related]
3. Role of N-terminal pro-B-type natriuretic peptide in the prediction of outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock. Sharma YP, Kanabar K, Santosh K, Kasinadhuni G, Krishnappa D. Indian Heart J; 2020 Sep; 72(4):302-305. PubMed ID: 32861389 [Abstract] [Full Text] [Related]
6. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T. J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002 [Abstract] [Full Text] [Related]
7. Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction. Klein A, Wiberg S, Hassager C, Winther-Jensen M, Frikke-Schmidt R, Bang LE, Lindholm MG, Holmvang L, Moeller-Helgestad O, Ravn HB, Jensen LO, Kjaergaard J, Moeller JE, Frydland M. Shock; 2020 Mar; 53(3):299-306. PubMed ID: 31058719 [Abstract] [Full Text] [Related]
8. Biomarkers in patients with Takotsubo cardiomyopathy compared to patients with acute anterior ST-elevation myocardial infarction. Højagergaard MA, Hassager C, Christensen TE, Bang LE, Gøtze JP, Ostrowski SR, Holmvang L, Frydland M. Biomarkers; 2020 Mar; 25(2):137-143. PubMed ID: 31902247 [Abstract] [Full Text] [Related]
9. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome. Tolppanen H, Rivas-Lasarte M, Lassus J, Sadoune M, Gayat E, Pulkki K, Arrigo M, Krastinova E, Sionis A, Parissis J, Spinar J, Januzzi J, Harjola VP, Mebazaa A, CardShock Investigators. Crit Care Med; 2017 Jul; 45(7):e666-e673. PubMed ID: 28403119 [Abstract] [Full Text] [Related]
10. Prognostic role of procalcitonin in ST-elevation myocardial infarction complicated by cardiogenic shock. Sharma YP, Kasinadhuni G, Santosh K, Parashar NK, Sharma R, Bootla D, Kanabar K, Krishnappa D. Asian Cardiovasc Thorac Ann; 2021 Oct; 29(8):751-757. PubMed ID: 33444068 [Abstract] [Full Text] [Related]